Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis

TBI (traumatic brain injury) is one of the most common causes of deaths and failure to return to society according to the latest statistics. Cerebrolysin is a drug approved for use in patients diagnosed with TBI. It is a mixture of neuropeptides derived from purified porcine brain proteins and multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarosz, Konrad, Kojder, Klaudyna, Andrzejewska, Agata, Solek-Pastuszka, Joanna, Jurczak, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046100/
https://www.ncbi.nlm.nih.gov/pubmed/36979317
http://dx.doi.org/10.3390/brainsci13030507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046100/
https://www.ncbi.nlm.nih.gov/pubmed/36979317
http://dx.doi.org/10.3390/brainsci13030507

Ejemplares similares